Direkt zum Inhalt
Merck

[Short-course chemotherapy of tuberculosis with pyrazinamide].

Nihon rinsho. Japanese journal of clinical medicine (1999-01-12)
S Asai, Y Futsuki, S Tomari, J Araki
ZUSAMMENFASSUNG

A 6-month regimen consisting of isoniazid (INH. 0.3-0.5 g).rifampicin (RFP. 0.3-0.45 g).pyrazinamide (PZA. 1.2-2.0 g) and streptomycin (SM. 0.75 g) or ethambutol (EB. 0.75-1.0 g) given for 2 month followed by isoniazid and rifampicin for 4 month is the preferred treatment for patients with fully susceptible organism, who adhere to treatment. Consideration should be given to treating all patients with directly observed treatment.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Pyrazincarboxamid
Pyrazinamid, European Pharmacopoeia (EP) Reference Standard